Comparison of adrenocorticotropic hormone stimulation test results started 2 versus 4 hours after trilostane administration in dogs with naturally occurring hyperadrenocorticism
- PMID: 24863172
- PMCID: PMC4857938
- DOI: 10.1111/jvim.12357
Comparison of adrenocorticotropic hormone stimulation test results started 2 versus 4 hours after trilostane administration in dogs with naturally occurring hyperadrenocorticism
Abstract
Background: Trilostane medical treatment of naturally occurring hyperadrenocorticism (NOH) in dogs is common, as is use of the adrenocorticotropic hormone (ACTH) stimulation test (ACTHst) in monitoring response to treatment. There is uncertainty regarding when the ACTHst should be started relative to time of trilostane administration.
Objective: To compare ACTHst results in dogs being treated for NOH with trilostane when the test is begun 2 versus 4 hours after trilostane administration.
Animals: Twenty-one privately owned dogs with NOH, each treated with trilostane for at least 30 days.
Methods: Each dog had 2 ACTHst completed, 1 started 2 hours and the other 4 hours after trilostane administration. The second test was started no sooner than 46 hours and no later than 74 hours after the first.
Results: For all 21 dogs, the mean post-ACTH serum cortisol concentration from tests started 2 hours after trilostane administration (5.4 ± 3.7 μg/dL) was significantly lower (P = .03) as compared with results from the tests started 4 hours after administration (6.5 ± 4.5 μg/dL).
Conclusions: Results of ACTHst started at different times yield significantly different results. Dogs with NOH, treated with trilostane, and monitored with ACTHst results should have all of their subsequent ACTHst tests begun at or about the same time after trilostane administration.
Keywords: Hyperadrenocorticism; Trilostane.
Copyright © 2014 by the American College of Veterinary Internal Medicine.
Figures
References
-
- Feldman EC. Distinguishing dogs with functional adrenocortical tumors from dogs with pituitary‐dependent hyperadrenocorticism. J Am Vet Med Assoc 1982;183:195–200. - PubMed
-
- Potts GO, Creange JE, Hardong HR, Schane HP. Trilostane, an orally active inhibitor of steroid biosynthesis. Steroids 1978;32:257–267. - PubMed
-
- Ramsey IK. Trilostane in dogs. Vet Clin Small Anim 2010;40:269–283. - PubMed
-
- Arteaga A, Dhand NK, McCann T, et al. Monitoring the response of canine hyperadrenocorticism to Trilostane treatment by assessment of acute phase protein concentrations. J Small Anim Practice 2010;51:204–209. - PubMed
-
- Bell R, Neiger R, McGrotty Y, Ramsey IK. Study of the effects of once daily doses of trilostane on cortisol concentrations and responsiveness to adrenocorticotropic hormone in hyperadrenocorticoid dogs. Vet Rec 2006;159:277–281. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources